OPT - יחס חוב להיוון בספרים Opthea Ltd.

לוגו תאגידי של חברת Opthea Limited (OPT)

Opthea Limited relies on a risky single-product model dependent on the test results of a single drug. Synergy with global laboratories is accelerating the market launch of sozinibercept. The total debt-to-market capitalization ratio reflects the dynamics of the liability structure, where the 0.00 indicator determines the magnitude of the metric. Management is focused on completing Phase 3 trials to update the standards of therapy for macular dystrophy.

opthea.com - חובות להיוון בספרים OPT (תקופה 04.07.2022 - 28.06.2025)
סחורת הדגל של Opthea Corp

Opthea Limited is advancing ophthalmological pharmaceuticals through partnerships to test the sozinibercept molecule. The financial stability of such projects is reflected in the debt-to-equity ratio. This coefficient measures the level of debt load relative to the book value of assets. It allows for an assessment of the risks of overpaying or undervaluing a business during M&A. By analyzing the percentage of debt to book capitalization, an investor determines the company's degree of financial leverage.